Stanford Researchers Find Protein Targets For Potential Treatment Of Multiple Sclerosis
Feb 19th 2008Drug InformationMultiple Sclerosis
Multiple sclerosis is not a single condition, but an ebbing and flowing of stages affecting the body’s central nervous system. Recognizing that pattern, researchers from the Stanford University School of Medicine have identified therapy targets that could lead to personalized treatments for patients at each phase of the illness. Essentially, the team cataloged all of the brain-tissue proteins that they found were distinct to three discrete stages of multiple sclerosis.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
